Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach
Abstract
Share and Cite
Mkhayar, K.; Daoui, O.; Haloui, R.; Elkhattabi, K.; Elabbouchi, A.; Chtita, S.; Samadi, A.; Elkhattabi, S. Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules 2024, 29, 426. https://doi.org/10.3390/molecules29020426
Mkhayar K, Daoui O, Haloui R, Elkhattabi K, Elabbouchi A, Chtita S, Samadi A, Elkhattabi S. Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules. 2024; 29(2):426. https://doi.org/10.3390/molecules29020426
Chicago/Turabian StyleMkhayar, Khaoula, Ossama Daoui, Rachid Haloui, Kaouakeb Elkhattabi, Abdelmoula Elabbouchi, Samir Chtita, Abdelouahid Samadi, and Souad Elkhattabi. 2024. "Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach" Molecules 29, no. 2: 426. https://doi.org/10.3390/molecules29020426
APA StyleMkhayar, K., Daoui, O., Haloui, R., Elkhattabi, K., Elabbouchi, A., Chtita, S., Samadi, A., & Elkhattabi, S. (2024). Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach. Molecules, 29(2), 426. https://doi.org/10.3390/molecules29020426

